Breakdown by a magnetic field of the superconducting fluctuations in the normal state: A simple phenomenological explanation

We first summarize our recent observations, through magnetization measurements in different low-Tc superconductors, of a rather sharp disappearance of the superconducting fluctuations in the normal state when the magnetic field approaches Hc2(0), the upper critical field extrapolated to T=0K. We propose that a crude phenomenological description of the observed effects may be obtained if the quantum limits associated with the uncertainty principle are introduced in the Gaussian-Ginzburg-Landau description of the fluctuation-induced magnetization.Comment: LaTeX, 8 pages, including 2 eps figures. Proceedings of SNS'04, Sitges, Spai

The in-plane paraconductivity in La_{2-x}Sr_xCuO_4 thin film superconductors at high reduced-temperatures: Independence of the normal-state pseudogap

The in-plane resistivity has been measured in $La_{2-x}Sr_xCuO_4$ (LSxCO) superconducting thin films of underdoped ($x=0.10,0.12$), optimally-doped ($x=0.15$) and overdoped ($x=0.20,0.25$) compositions. These films were grown on (100)SrTiO$_3$ substrates, and have about 150 nm thickness. The in-plane conductivity induced by superconducting fluctuations above the superconducting transition (the so-called in-plane paraconductivity, $\Delta\sigma_{ab}$) was extracted from these data in the reduced-temperature range 10^{-2}\lsim\epsilon\equiv\ln(T/\Tc)\lsim1. Such a $\Delta\sigma_{ab}(\epsilon)$ was then analyzed in terms of the mean-field--like Gaussian-Ginzburg-Landau (GGL) approach extended to the high-$\epsilon$ region by means of the introduction of a total-energy cutoff, which takes into account both the kinetic energy and the quantum localization energy of each fluctuating mode. Our results strongly suggest that at all temperatures above Tc, including the high reduced-temperature region, the doping mainly affects in LSxCO thin films the normal-state properties and that its influence on the superconducting fluctuations is relatively moderate: Even in the high-$\epsilon$ region, the in-plane paraconductivity is found to be independent of the opening of a pseudogap in the normal state of the underdoped films.Comment: 35 pages including 10 figures and 1 tabl

Lesão intracraniana que respondeu ao tratamento anti-tuberculoso em paciente infectado pelo HIV

Cerebral tuberculomas constitute a major differential diagnosis of cerebral toxoplasmosis in human immunodeficiency virus (HIV)-infected patients in developing countries. We report the case of a 34-year old woman co-infected with HIV and possible disseminated tuberculosis (hepatitis, lymphadenopathy, and pleural effusion) who presented a large and solitary intracranial mass lesion. Despite extensive diagnostic efforts, including brain, ganglionar, and liver biopsies, no definitive diagnosis was reached. However, a trial with first-line antituberculous drugs led to a significant clinical and radiological improvement. Atypical presentations of cerebral tuberculomas should always be considered in the differential diagnosis of intracranial mass lesions in HIV-infected patients and a trial with antituberculous drugs is a valuable strategy to infer the diagnosis in a subset of patients.Os tuberculomas cerebrais constituem diagnóstico diferencial importante da toxoplasmose cerebral em pacientes infectados pelo vírus da imunodeficiência humana (HIV) de países em desenvolvimento. Os autores relatam o caso de uma mulher HIV positiva de 34 anos de idade, que apresentou provável tuberculose disseminada (hepatite, adenomegalia, e derrame pleural) associada à lesão expansiva cerebral única e gigante. Apesar dos esforços diagnósticos realizados, incluindo biópsia cerebral, ganglionar e hepática, o diagnóstico etiológico não foi confirmado. Porém, a resposta clínico-radiológica ao tratamento tuberculostático permitiu definir o diagnóstico de tuberculoma cerebral e a paciente teve alta hospitalar. Apresentações atípicas de tuberculomas cerebrais devem ser sempre consideradas no diagnóstico diferencial das lesões expansivas cerebrais em pacientes infectados pelo HIV e o uso do tratamento tuberculostático constitui ferramenta útil na definição diagnóstica em um sub-grupo de paciente

Diets and trophic structure of fish assemblages in a large and unexplored subtropical river: The Uruguay river

This article belongs to the Special Issue Trophic Interactions in Warm Freshwater EcosystemsThe Neotropics represent a hotspot for freshwater biodiversity with vast number of fish species of scarce ecological knowledge. This holds true for the Uruguay River, where fish assemblages and their diets remain unexplored. Fish assemblages were surveyed in 14 sites along the river main course, from headwaters to mouth (approximately 1800 km), with the aim to identify the trophic roles of fishes and to describe trophic structure of these assemblages, following standardized sampling campaigns and laboratory procedures. One hundred species (2309 gut contents) were analysed and classified into four trophic groups subdivided into eight lower-level groups: Piscivore, piscivore-invertivore, detritivore, omnivore-detritivore, omnivore-invertivore, omnivore-planktivore and omnivore-herbivore. The trophic structure of the assemblages varied along the river, with the relative species richness of fish consuming terrestrial invertebrates increasing towards the middle river section, probably driven by the large floodplains in that areas, supporting global theories such as the flood pulse concept. This study describes the feeding habits of fish along the Uruguay River, being the first dietary description for 29 species. This knowledge is essential for management and conservation, serving as baseline in the context of future environmental changes while generating novel evidence on the functioning of ecosystems in this scarcely studied climatic region

Geometric phase in the Kitaev honeycomb model and scaling behavior at critical points

In this paper a geometric phase of the Kitaev honeycomb model is derived and proposed to characterize the topological quantum phase transition. The simultaneous rotation of two spins is crucial to generate the geometric phase for the multi-spin in a unit-cell unlike the one-spin case. It is found that the ground-state geometric phase, which is non-analytic at the critical points, possesses zigzagging behavior in the gapless $B$ phase of non-Abelian anyon excitations, but is a smooth function in the gapped $A$ phase. Furthermore, the finite-size scaling behavior of the non-analytic geometric phase along with its first- and second-order partial derivatives in the vicinity of critical points is shown to exhibit the universality. The divergent second-order derivative of geometric phase in the thermodynamic limit indicates the typical second-order phase transition and thus the topological quantum phase transition can be well described in terms of the geometric-phase.Comment: 7 pages, 8 figure

Ring enhancing intracranial lesion responding to antituberculous treatment in an HIV-infected patient

Cerebral tuberculomas constitute a major differential diagnosis of cerebral toxoplasmosis in human immunodeficiency virus (HIV)-infected patients in developing countries. We report the case of a 34-year old woman co-infected with HIV and possible disseminated tuberculosis (hepatitis, lymphadenopathy, and pleural effusion) who presented a large and solitary intracranial mass lesion. Despite extensive diagnostic efforts, including brain, ganglionar, and liver biopsies, no definitive diagnosis was reached. However, a trial with first-line antituberculous drugs led to a significant clinical and radiological improvement. Atypical presentations of cerebral tuberculomas should always be considered in the differential diagnosis of intracranial mass lesions in HIV-infected patients and a trial with antituberculous drugs is a valuable strategy to infer the diagnosis in a subset of patients

Fault seal analysis of a natural CO2 reservoir in the Southern North Sea

AbstractA geomechanical and fault seal analysis of the fault-bound natural CO2 reservoir of the Fizzy Field, Southern North Sea, shows that reactivation of, and leakage along the bounding fault is unlikely. Reservoirs are juxtaposed along the fault but shale-gouge ratio calculations indicate that the fault rock prohibits across-fault leakage of CO2. This study illustrates that, even though the fault is orientated favourably for reactivation relative to present day stress and uncertainties about the geometries remain, fault seal is not the limiting factor in retention of CO2 at the Fizzy field

Palynology and chronology of hyaena coprolites from the Piñar karstic Caves Las Ventanas and Carihuela, southern Spain

This paper presents pollen analyses and radiocarbon dating on Crocuta coprolites from Las Ventanas (LV) and Carihuela (Car) Caves in southern Spain (Granada), with the aim of reconstructing the environmental conditions of these hominin sites. The LV coprolites are radiocarbon dated from c. 37,890 to 6980 cal yr BP, and the Car coprolites from c. 31,063 to 7861 cal yr BP. Overall, the palaeoecological scenario inferred from both coprolite series display similar patterns, with Pinus, Poaceae, and Artemisia as dominant during the full Pleistocene, and an important contribution of Quercus in the most recently dated coprolite samples. While the palynology is consistent with results of former investigations on the past environments in the region as obtained from other deposits (peat bogs, cave infills), the Late Glacial and Holocene chronology of several coprolites in both sites is in conflict with the generally accepted timing of extinction of Crocuta in western Europe. A discussion on the taphonomical processes and potential sources of carbon contamination of the radiocarbon samples is provided. The correlation between pollen from coprolites and from sedimentary records, and the paucity of the fossil bone record suggests nevertheless, that a late survival of Crocuta in southern Spain should not be categorically discarded

HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade

Background: Identification of HER2-positive breast cancers with high anti-HER2 sensitivity could help de-escalate chemotherapy. Here, we tested a clinically applicable RNA-based assay that combines ERBB2 and the HER2-enriched (HER2-E) intrinsic subtype in HER2-positive disease treated with dual HER2-blockade without chemotherapy. Methods: A research-based PAM50 assay was applied in 422 HER2-positive tumors from five II-III clinical trials (SOLTI-PAMELA, TBCRC023, TBCRC006, PER-ELISA, EGF104090). In SOLTI-PAMELA, TBCRC023, TBCRC006, and PER-ELISA, all patients had early disease and were treated with neoadjuvant lapatinib or pertuzumab plus trastuzumab for 12-24 weeks. Primary outcome was pathological complete response (pCR). In EGF104900, 296 women with advanced disease were randomized to receive either lapatinib alone or lapatinib plus trastuzumab. Progression-free survival (PFS), overall response rate (ORR), and overall survival (OS) were evaluated. Results: A total of 305 patients with early and 117 patients with advanced HER2-positive disease were analyzed. In early disease, HER2-E represented 83.8% and 44.7% of ERBB2-high and ERBB2-low tumors, respectively. Following lapatinib and trastuzumab, the HER2-E and ERBB2 (HER2-E/ERBB2)-high group showed a higher pCR rate compared to the rest (44.5%, 95% confidence interval [CI] = 35.4% to 53.9% vs 11.6%, 95% CI = 6.9% to 18.0%; adjusted odds ratio [OR] = 6.05, 95% CI = 3.10 to 11.80, P <. 001). Similar findings were observed with neoadjuvant trastuzumab and pertuzumab (pCR rate of 66.7% in HER2-E/ERBB2-high, 95% CI = 22.3% to 95.7% vs 14.7% in others, 95% CI = 4.9% to 31.1%; adjusted OR = 11.60, 95% CI = 1.66 to 81.10, P =. 01). In the advanced setting, the HER2-E/ERBB2-high group was independently associated with longer PFS (hazard ratio [HR] = 0.52, 95% CI = 0.35 to 0.79, P <. 001); higher ORR (16.3%, 95% CI = 8.9% to 26.2% vs 3.7%, 95% CI = 0.8% to 10.3%, P =. 02); and longer OS (HR = 0.66, 95% CI = 0.44 to 0.97, P =. 01). Conclusions: Combining HER2-E subtype and ERBB2 mRNA into a single assay identifies tumors with high responsiveness to HER2-targeted therapy. This biomarker could help de-escalate chemotherapy in approximately 40% of patients with HER2-positive breast cancer